The global CBD pet care market, which includes products for animals such as dogs, cats, and horses, was valued at approximately $125 million in 2020 and will grow at a compound annual growth rate (CAGR) of 40.3% from 2021 to 2028 It is expected that.
SCOTTSDALE, AZ / ACCESSWIRE / October 29, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD industry, taps into the rapidly expanding CBD pet care market with a bold move into equine products We are preparing to do so. With the market expected to soar at a CAGR of 40.3% through 2028, CBDL is taking a strategic approach to underserved niches within this $125 million industry. By focusing on high-demand equine health products, CBDL aims to differentiate itself from competitors while delivering maximum value to investors.
CBDL's equine-specific products offer a powerful blend of natural health and therapeutic benefits, meeting the demand of pet owners who are increasingly seeking alternative health solutions for their animals. Unlike the crowded household pet sector, the equine sector is a relatively untapped market in the CBD space, and CBDL is able to leverage its proprietary formulations and quality-oriented product development to build a strong market foothold. .
“As a publicly traded company, CBD Life Sciences has the distinct advantage of bringing transparency and robust standards to a rapidly growing industry,” said CBDL CEO Lisa Nelson. “Our innovative equine product line is positioned to capture significant market share in a rapidly growing sector, offering shareholders and investors a unique investment in a high-demand, low-competition sector. Masu.”
This horse-focused strategy is supported by growing consumer demand for safe, effective and scientifically-backed products that improve animal health. CBDL's equine formulations are meticulously crafted to provide physical and mental support, with benefits such as reduced inflammation, improved recovery time, and improved overall health. Developed by veterinary experts to address the unique needs of horses.
The decision to target equine products also aligns with broader market trends toward natural, integrative health solutions for pets, as highlighted in the Grand View Research report on CBD pet market size, share and trend analysis. We are doing so. According to the report, pet owners are increasingly interested in CBD-based products to promote the health of their animals, which not only supports CBDL's direction, but also supports the brand's expanding pet care line. suggests high growth potential.
Positioned to benefit shareholders with high growth and market visibility
CBDL's entry into the equine market is expected to generate significant revenue growth for the company, making it an attractive investment opportunity for shareholders seeking exposure to both the fast-growing CBD sector and the emerging pet care industry. . CBDL has demonstrated a proven track record of revenue growth and product success, achieving an impressive growth of 1405.46% across its various product categories since the beginning of 2024. The company's reputation and stability as a publicly traded company provides added security for shareholders, who will benefit as CBDL expands its footprint in emerging markets.
Grand View Research Link: https://www.grandviewresearch.com/industry-analysis/cannabidiol-pet-market
About CBD Life Sciences
CBD Life Sciences, Inc. (OTC PINK:CBDL) is a leading innovator in the CBD and wellness industry, committed to developing high-quality, scientifically-backed products that promote health and well-being. CBD Life Sciences strives to provide best-in-class solutions to meet the needs of today's consumers, from pain relief to overall health.
Follow us on social media for updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com
Forward-looking statements
Except for historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in the forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc.'s OTC Markets filings. This may identify certain factors that could cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release contains forward-looking statements that are based on certain assumptions and reflect management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. These factors include general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will deliver expected benefits; Increasing competition. Availability and cost of capital. Ability to identify, develop and achieve commercial success. The level of spending required to maintain and improve the quality of service. Economic changes. changes in laws and regulations, including norms and standards, intellectual property rights, and taxation; or other unexpected matters. our ability to secure and maintain strategic relationships and distribution agreements; The Company disclaims any intention or obligation to update or revise any forward-looking statements to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
contact address
lisa nelson
CEO
cbdvaultaz@gmail.com
4802091720
Related images
Source: CBD Life Sciences
View the original press release at accesswire.com
